国际皮肤性病学杂志    2003 29 (2): 123-126   ISSN: 2096-5540  CN: 32-1880/R   HIV-1转录调控机制的研究进展 崔凡, 刘维达 中国医学科学院、中国协和医科大学皮肤病研究所, 南京210042 收稿日期 2002-10-08  修回日期 null  网络版发布日期 null 参考文献  [1] Greene WC, Peterlin BM. Charting HIV;s remarkable voyage throughthe cell:Basic science as a passport to future therapy. Nat Med. 2002, 8(7):673-680. [2] Majello B, Napo1litano G, De Luca P, et al. Recruitment of human TBP selectively activates RNA polymerase Ⅱ TATA-dependent promoters. J Biol Chem. 1998, 273(26):16509-16516. [3] Zenzie-Gregory B, Sheridan P, Jones KA, etal. HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site. J Biol Chem, 1993, 268 (21):15823-15832. [4] Sune C, Garcia-Blanco MA. Spl transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J Virol. 1995,69(10):6572-6576. [5] Kretzschmar M, Meisterernst M, Scheidereit C, et al. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev, 1992, 6(5):761-774. [6] Takada N, Sanda T, Okamoto H, et al. RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions. J Virol, 2002, 76 (16):8019-8030. [7] Fujii R, Okamoto M, Aratani S, et al. A Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type I. J Biol Chem, 2001, 276(8):5445-5451. [8] Chen-Park FE, Huang DB, Noro B, et al. The kappa B DNA se quence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J Biol Chem. 2002, 277 (27):24701-24708. [9] Al-Harthi L, Roebuck KA. Human immunodeficiency virus type-1 transcription:role of the 5'-untranslated leader region (review). Int J Mol Med, 1998, 1(5):875-881. [10] Wei P, Garber ME, Fang SM, et al. A novel CDK9-associated C type cyclin interacts directly with HIV-1 Ta and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998,92 (4):451-462. [11] Tasara T, Hottiger MO, Hubscher U. Functional genomics in HIV-1 virus replication:protein-protein interactions as a basis for recruiting the host cell machinery for viral propagation. Biol Chem, 2001, 382 (7):993-999. [12] Garber ME, Wei P, KewalRamani VN, et al. The interaction betweenHIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Der, 1998, 12(22):3512-3527. [13] Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase Ⅱ. Mol Cell Biol, 2000, 20(8):2629-2634. [14] Kim YK, Bourgeois CF. Isel C, et al. Phosphorylation of the RNA polymerase Ⅱ carboxyl-terminal domain by CDK9 is directly responsi ble for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol, 2002, 22(13):4622-4637. [15] Garber ME, Mayall TP, Suess EM, et al. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol, 2000, 20 (18):6958-6969. [16] Nekhai S, Zhou M, Fernandez A, et al. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription. Biochem J, 2002, 364 (Pt 3):649-657. [17] Barboric M. Nissen RM, Kanazawa S, et al. NF-kappaB binds P-TE Fb to stimulate transcriptional elongation by RNA polymerase Ⅱ. Mol Cell, 2001, 8(2):327-337. [18] Yang Z, Zhu Q, Luo K,et al. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature, 2001. 414(6861):317-322. [19] Cook JA, August A. Henderson AJ. Recruitment of phosphatidylinosi tol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism. J Immunol, 2002, 169(1):254-260. [20] Jordan A, Defechereux P, Verdin E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and re sponse to Tat transactivation. EMBO J, 2001,20(7):1726-1738. 通讯作者: